biomed

Savoirs

The involvement of the MAPK signalling pathway in the adaptation of MCF-7 cells to long-term oestrogen deprivation

Martin L-A, Chan Cmw, Marshall C, Dowsett, Dowsett M

Savoirs

Genetic variants of CYP19 (aromatase) and breast cancer risk

Nedelcheva, Harada N, Yoshimura N, Haraldsen E, Lønning Pe, Erikstein B, Kåresen R, Kristensen T, Børresen-Dale, Børresen-Dale A-L

Savoirs

Hairy and enhancer of split homolog-1 (HES-1) mediates the proliferative effect of Beta-estradiol on breast cancer cell lines

Ström A, Arai N, Leers J, Gustafsson, Gustafsson J-Å

Savoirs

Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways

Lundholt Bk, Briand P, Lykkesfeldt, Lykkesfeldt Ae

Savoirs

Mammary-specific targeting of the murine BRCA2 breast cancer susceptibility gene in mice

Collins Nk, Mcallister Ka, Bennett Lm, Wagner K-U, Ward T, Malphurs J, Goulding G, Eddy Em, Davis Bj, Wiseman, Wiseman Rw

Savoirs

HRAS1 minisatellite alleles and breast cancer in Spanish women under age forty years

Marín-Garcia P, Vega A, Martínez Ji, Barros F, Chavez Fj, Ruiz-Ponte C, Chirivella I, Lluch A, Cervantes A, García-Conde I, Armengod Me, Carracedo A

Savoirs

X chromosome inactivation pattern in female patients with breast cancer

Kristiansen M, Langer A, Knudsen Gp, Weber Bl, Børresen-Dale A-L, Ørstavik, Ørstavik Kh

Savoirs

Mutational analysis of BRCA1 and BRCA2 genes in Spanish women with early-onset breast cancer

Martínez-Ferrandis Ji, Vega A, Marín-Garcia P, Barros F, Chaves Fj, Carracedo A, Armengod Me, Chirivella I, Lluch A, García-Conde J, Cervantes A

Savoirs

One test to identify 50% of all Norwegian BRCA1 mutations

Møller P, Hovig E, Lycke K, Stacy Rap, Dahlberg Oj, Hagen A, Hagen B, Løvslett K, Qvist H, Heimdal, Heimdal K

Savoirs

BRCA1, BRCA2 and pedigree genetic analysis to determine genetic risk in the UK Royal Marsden Hospital tamoxifen prevention trial

Kote-Jarai Z, Powles Tp, Ashley S, Easton Df, Assersohn L, Sodha N, Dowsett M, Gusterson B, Tidy A, Mitchell G, Eeles Ra

Savoirs

Clinical and pathological characteristics in patients with BRCA1/2-mutation associated with breast cancer (BC) with a long clinical follow-up

Díez O, Pericay C, Domènech M, Brunet J, Cortés J, Balmaña J, Gómez A, López Jj, Alonso Mc, Baiget, Baiget M

Savoirs

Expression profiling of BRCA1 associated breast tumors

Berns Emjj, Verhoog L, Foekens Ja, Klijn, Klijn Jgm, Van

Savoirs

Identification of two novel breast cancer associated genes by the differential display method

Maass N, Nagasaki K, Jacobs Vr, Jonat, Jonat W

Savoirs

Mammary epithelial cells immortalized by over-expression of the catalytic subunit of human telomerase may represent a model for mammary epithelial differentiation

Direnzo J, Rivera-Gonzalez R, Brown M, Brown

Savoirs

Genetic alterations in ductal carcinoma in situ and invasive carcinoma of the breast

Robanus-Maandag E, Bosch C, Vos C, Peterse H, Van

Savoirs

Ribozymes targeting the tumor suppressor BRCA1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in HBL100 breast cancer cell line

Lafarge S, Ferrara M, Bignon, Bignon Yj

Savoirs

Molecular analyses of human breast cancer metastasis: genetic markers of progression

Driouch K, Lidereau, Lidereau R

Savoirs

Development of a high throughput, molecular diagnostic assay for predicting telomerase activity in breast cancer cell lines and tissues

Elmore L, Akalin A, Gollahon L, Clarke G, Grimes M, Burks Rt, Ferreira-Gonzalez A, Garrett C, Holt, Holt S

Savoirs

Estrogen-dependent c-jun upregulation may control cyclin D1 expression

Planas-Silva Md, Weinberg Ra, Liu, Weinberg

Savoirs

Low frequency of p16INK4a promoter methylation in mammary carcinomas as revealed by positive display of methylated sites

Lilischkis R, Kneitz H, Kreipe, Kreipe H

Savoirs

Expression of variant forms of the MUC1 gene correlates with the invasiveness of breast cancer cells

Zeillinger R, Schmid B, Tong D, Fasching B, Schiebl I, Stimpfl M, Obermair A, Leodolter, Leodolter S

Savoirs

Excluding TTC4 as a target for loss on chromosome 1p31 in human breast cancer

Hey Y, Brintnell W, James L, Varley J, Varley

Savoirs

Analysis of chromosome alterations and the E-cadherin and FHIT genes in lobular breast cancer

Ingvarsson S, Huiping C, Jonasson Jg, Agnarsson, Agnarsson Ba

Savoirs

Loss of heterozygosity on chromosome arm 16q in breast cancer: clinical, molecular and statistical approaches

Cleton-Jansen A-M, Eilers Phc, Bonsing Ba, Smit Vthbm, Cornelisse, Cornelisse Cj, Van, Ter

Savoirs

Modulation of ATM gene expression in a murine mammary epithelial cell line

Vutskits Gv, Salmon P, Soriano Jv, Cudre-Mauroux C, Trono D, Montesano R, Sappino, Sappino A-P

Savoirs

Constitutional alterations of the ATM gene in early-onset sporadic breast cancer

Maillet P, Bonnefoi H, Sappino, Sappino A-P

Savoirs

P53 mutations in breast and ovarian carcinomas from BRCA1 and 2 mutation carriers and noncarriers

Sensi E, Ghimenti C, Cipollini G, Iandolo D, Naccarato G, Viacava P, Bevilacqua G, Caligo, Caligo Ma

Savoirs

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients

Langerød A, Andersen Ti, Bukholm I, Børresen

Savoirs

Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients

Alsner J, Yilmaz M, Guldberg P, Hansen Ll, Overgaard, Overgaard J

Savoirs

Anti-HER2 mAb plus calicheamicin immunoconjugate linked on liposomal vinorelbine induces ADCC and apoptosis in HER2-positive high grade DCIS

Giannos J, Ginopulos, Ginopulos P